Dyslipidemia News, Research | Endocrine, Metabolic Disorder News



Featured Article

Latest News

LDL-C Lowering Combo Therapy Nexlizet Now Available

Nexlizet (bempedoic acid and ezetimibe; Esperion) is now available for use as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who require additional lowering of LDL-C.
Next post in Dyslipidemia